<PAGE>
--------------------------------------------------------------------------------
PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT
by and among
Critical Home Care, Inc.
and
the parties named herein on Schedule 1, as Purchasers
September 21, 2004
--------------------------------------------------------------------------------
<PAGE>
This PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT (this
"AGREEMENT")
is dated as of September 21, 2004, among
Critical Home Care, Inc., a Nevada
corporation (the "COMPANY"), and the
purchasers identified on SCHEDULE 1 hereto
(each a "PURCHASER" and collectively the
"PURCHASERS").
WHEREAS, subject to the terms and conditions set forth in this
Agreement
and pursuant to Section 4(2) of the
Securities Act (as defined below), and Rule
506 promulgated thereunder, the Company
desires to issue and sell to the
Purchasers, and the Purchasers, severally
and not jointly, desire to purchase
from the Company in the aggregate,
$5,000,000 principal amount of the Seller's
6% Promissory Notes and Warrants to
purchase 3,150,000 shares of Common Stock.
NOW, THEREFORE, in consideration of the mutual covenants contained
in
this Agreement, and for other good and
valuable consideration the receipt and
adequacy of which are hereby acknowledged,
the Company and each Purchaser agree
as follows:
ARTICLE I
DEFINITIONS
1.1
DEFINITIONS.
In addition to the terms defined elsewhere in this Agreement, for
all
purposes of this Agreement, the following
terms have the meanings indicated in
this Section 1.1:
"ACTION" shall have the meaning ascribed to such term in Section
3.1(j).
"AFFILIATE" means any Person that, directly or indirectly through
one or
more intermediaries, controls or is
controlled by or is under common control
with a Person, as such terms are used in
and construed under Rule 144. With
respect to a Purchaser, any investment fund
or managed account that is managed
on a discretionary basis by the same
investment manager as such Purchaser will
be deemed to be an Affiliate of such
Purchaser.
"AGREEMENT" shall have the meaning ascribed to such term in the
Preamble.
"BUSINESS DAY" means any day except Saturday, Sunday and any day
which
shall be a federal legal holiday or a day
on which banking institutions in the
State of Michigan are authorized or
required by law or other governmental action
to close.
"CLOSING" shall have the meaning ascribed to such term in
Section
2.1(a).
"CLOSING DATE" shall have the meaning ascribed to such term in
Section
2.1(a).
"COMMISSION" means the Securities and Exchange Commission.
"COMMON STOCK" means the common stock of the Company, $0.01 par
value
per share, and any securities into which
such common stock may hereafter be
reclassified.
<PAGE>
"COMMON STOCK EQUIVALENTS" means any securities of the Company or
the
Subsidiaries which would entitle the holder
thereof to acquire at any time
Common Stock, including without limitation,
any debt, preferred stock, rights,
options, warrants or other instrument that
is at any time convertible into or
exchangeable for, or otherwise entitles the
holder thereof to receive, Common
Stock.
"COMPANY" shall have the meaning ascribed to such term in the
Preamble.
"DISCLOSURE SCHEDULES" means the Disclosure Schedules
concurrently
delivered herewith.
"EFFECTIVE DATE" means the date that the Registration Statement is
first
declared effective by the Commission.
"ENVIRONMENTAL LAWS" shall have the meaning ascribed to such term
in
Section 3.1(y).
"EXCHANGE ACT" means the Securities Exchange Act of 1934, as
amended.
"GAAP" shall have the meaning ascribed to such term in Section
3.1(h).
"GOVERNMENTAL AUTHORIZATIONS" shall have the meaning ascribed to
such
term in Section 3.1(m).
"HAZARDOUS SUBSTANCES" shall have the meaning ascribed to such term
in
Section 3.1(y).
"INDEMNIFIED PARTY" shall have the meaning ascribed to such term
in
Section 5.3.
"INDEMNIFYING PARTY" shall have the meaning ascribed to such term
in
Section 5.3.
"INTELLECTUAL PROPERTY" shall have the meaning ascribed to such
term in
Section 3.1(o).
"INVESTOR RIGHTS AGREEMENT" means the Investor Rights Agreement,
dated
as of the date of this Agreement, between
the Company and each of the
Purchasers, in the form of EXHIBIT A
hereto.
"LIEN" means a lien, charge, security interest, encumbrance, right
of
first refusal or other restriction, except
for a lien for current taxes not yet
due and payable and a minor imperfection of
title, if any, not material in
nature or amount and not materially
detracting from the value or impairing the
use of the property subject thereto or
impairing the operations or proposed
operations of the Company.
"MATERIAL ADVERSE EFFECT" shall have the meaning ascribed to such
term
in Section 3.1(b).
"PERSON" means an individual or corporation, partnership,
trust,
incorporated or unincorporated association,
joint venture, limited liability
company, joint stock company, government
(or an agency or subdivision thereof)
or other entity of any kind.
"PREMISES" shall have the meaning ascribed to such term in
Section
3.1(y).
3
<PAGE>
"PROMISSORY NOTES" means the 6% Promissory Notes of the Seller,
which
shall be in the form attached as EXHIBIT B
hereto.
"PURCHASER" shall have the meaning ascribed to such term in the
Preamble.
"REGISTRATION STATEMENT" means a registration statement meeting
the
requirements set forth in the Investor
Rights Agreement and covering the resale
by the Purchasers of the Warrant
Shares.
"RIGHTS" shall have the meaning ascribed to such term in Section
3.1(o).
"RULE 144" means Rule 144 promulgated by the Commission pursuant to
the
Securities Act, as such Rule may be amended
from time to time, or any similar
rule or regulation hereafter adopted by the
Commission having substantially the
same effect as such Rule.
"SEC
REPORTS" shall have the meaning ascribed to such term in
Section
3.1(h).
"SECURITIES" means the Promissory Notes, the Warrants and the
Warrant
Shares.
"SECURITIES ACT" means the Securities Act of 1933, as amended.
"SUBSCRIPTION AMOUNT" means, as to each Purchaser, the amount set
forth
beside such Purchaser's name on SCHEDULE 1
hereto, in United States dollars and
in immediately available funds.
"SUBSIDIARY" means, with respect to any entity, any corporation or
other
organization of which securities or other
ownership interest having ordinary
voting power to elect a majority of the
board of directors or other persons
performing similar functions, are directly
or indirectly owned by such entity or
of which such entity is a partner or is,
directly or indirectly, the beneficial
owner of 50% or more of any class of equity
securities or equivalent profit
participation interests.
"TRADING DAY" means (i) a day on which the Common Stock is traded
on a
Trading Market, or (ii) if the Common Stock
is not listed on a Trading Market, a
day on which the Common Stock is traded on
the over-the-counter market, as
reported by the OTC Bulletin Board, or
(iii) if the Common Stock is not quoted
on the OTC Bulletin Board, a day on which
the Common Stock is quoted in the
over-the-counter market as reported by the
National Quotation Bureau
Incorporated (or any similar organization
or agency succeeding to its functions
of reporting prices); provided, that in the
event that the Common Stock is not
listed or quoted as set forth in (i), (ii)
and (iii) hereof, then Trading Day
shall mean a Business Day.
"TRADING MARKET" means the following markets or exchanges, if any,
on
which the Common Stock is listed or quoted
for trading on the date in question:
the American Stock Exchange, the New York
Stock Exchange, the Nasdaq National
Market or the Nasdaq SmallCap Market.
"TRANSACTION DOCUMENTS" means this Agreement, the Investor
Rights
Agreement, the Promissory Notes, the
Warrants and any other documents or
agreements executed in connection with the
transactions contemplated hereunder.
4
<PAGE>
"WARRANTS" means the Common Stock Purchase Warrants, in the form
of
EXHIBIT C hereto.
"WARRANT SHARES" means the shares of Common Stock issuable upon
exercise
of the Warrants.
ARTICLE II
PURCHASE AND SALE
2.1
CLOSING.
(a)
The closing of the transactions contemplated under this
Agreement (the "CLOSING") will take place
as promptly as practicable, but no
later than five (5) Business Days following
satisfaction or waiver of the
conditions set forth in Sections 2.2 and
2.3 (other than those conditions which
by their terms are not to be satisfied or
waived until the Closing), at the
offices of Wiggin and Dana LLP, 400
Atlantic Street, Stamford, CT 06901 (or
remotely via exchange of documents and
signatures) or at such other place or day
as may be mutually acceptable to the
Purchasers and the Company. The date on
which the Closing occurs is the "CLOSING
DATE".
(b)
At the Closing, the Purchasers shall purchase, severally and
not
jointly, and the Company shall issue and
sell, in the aggregate, $5,000,000
principal amount of Promissory Notes and
Warrants to purchase 3,150,000 shares
of Common Stock on the Closing Date. Each
Purchaser shall purchase from the
Company, and the Company shall issue and
sell to each Purchaser, Promissory
Notes in a principal amount equal to such
Purchaser's Subscription Amount and a
Warrant to purchase the number of Shares as
indicated on SCHEDULE 1 for such
Purchaser.
2.2
CONDITIONS TO OBLIGATIONS OF PURCHASERS TO EFFECT THE CLOSING.
The obligations of each Purchaser to effect the Closing and the
transactions contemplated by this Agreement
shall be subject to the satisfaction
at or prior to the Closing of each of the
following conditions, any of which may
be waived, in writing, by such
Purchaser:
(a)
At the Closing (unless otherwise specified below) the Company
shall deliver or cause to be delivered to
each Purchaser the following:
(i)
this Agreement, duly executed by the Company;
(ii) a
certificate evidencing the Promissory Note in the
principal amount equal to such Purchaser's
Subscription Amount as set forth on
SCHEDULE 1 hereto, registered in the name
of such Purchaser;
(iii) a Warrant,
registered in the name of such Purchaser,
pursuant to which such Purchaser shall have
the right to acquire up to the
number of shares of Common Stock as set
forth on SCHEDULE 1 hereto;
(iv) the
Investor Rights Agreement, duly executed by the
Company;
5
<PAGE>
(v)
a legal opinion of Kerr, Russell and Weber, PLC, counsel
to the Company, in the form of EXHIBIT D
hereto; and
(vi) a
legal opinion of Marquis & Aurbach, Nevada counsel to
the Company, in the form of EXHIBIT E
hereto; and
(vii) a
certificate of the Secretary of the Seller (the
"SECRETARY'S CERTIFICATE"), attaching a
true copy of the Certificate of
Incorporation and Bylaws of the Seller, as
amended to the Closing Date, and
attaching true and complete copies of the
resolutions of the Board of Directors
of the Seller authorizing the execution,
delivery and performance of this
Agreement and the other Transaction
Documents.
(viii) A wire transfer
representing the Purchasers' reasonable
legal fees and other expenses as described
in Section 6.1 hereof; such fee may,
at the election of the Purchasers, be paid
out of the funds due from the
Purchasers at the Closing.
(b)
All representations and warranties of the Company contained
herein shall remain true and correct as of
the Closing Date as though such
representations and warranties were made on
such date (except those
representations and warranties that address
matters only as of a particular date
will remain true and correct as of such
date).
(c)
As of the Closing Date, there shall have been no Material
Adverse Effect with respect to the Company
since the date hereof.
(d)
From the date hereof to the Closing Date, trading in the Common
Stock shall not have been suspended by the
Commission (except for any suspension
of trading of limited duration agreed to by
the Company, which suspension shall
be terminated prior to the Closing), and,
at any time prior to the Closing Date,
trading in securities generally as reported
by Bloomberg Financial Markets shall
not have been suspended or limited, or
minimum prices shall not have been
established on securities whose trades are
reported by such service, or on any
Trading Market, nor shall a banking
moratorium have been declared either by the
United States or New York State
authorities.
(e)
John Elliott and Lawrence Kuhnert shall have executed an
agreement, in form and substance acceptable
to the Purchasers, waiving their
preemptive rights with respect to the
issuance by the Seller of the Securities.
2.3.
CONDITIONS TO OBLIGATIONS OF THE COMPANY TO EFFECT THE CLOSING.
(a)
The obligations of the Company to effect the Closing and the
transactions contemplated by this Agreement
shall be subject to the satisfaction
at or prior to the Closing of each of the
following conditions, any of which may
be waived, in writing, by the Company. At
the Closing, each Purchaser shall
deliver or cause to be delivered to the
Company the following:
(i)
this Agreement, duly executed by such Purchaser;
(ii) such
Purchaser's Subscription Amount, by wire transfer
of immediately available funds as provided
in the Closing Escrow Agreement; and
6
<PAGE>
(iii) the
Investor Rights Agreement, duly executed by such
Purchaser.
(b)
All representations and warranties of each of the Purchasers
contained herein shall remain true and
correct as of the Closing Date as though
such representations and warranties were
made on such date.
ARTICLE III
REPRESENTATIONS AND WARRANTIES
3.1
REPRESENTATIONS AND WARRANTIES OF THE COMPANY.
Except as set forth under the corresponding section of the
Disclosure
Schedules delivered concurrently herewith,
the Company hereby makes the
following representations and warranties as
of the date hereof and as of the
Closing Date to each Purchaser:
(A)
SUBSIDIARIES. Except as listed in the SEC Reports, the Company
has no direct or indirect Subsidiaries.
(B)
ORGANIZATION AND QUALIFICATION. Each of the Company and the
Subsidiaries is an entity duly incorporated
or otherwise organized, validly
existing and in good standing under the
laws of the jurisdiction of its
incorporation or organization (as
applicable), with the requisite corporate
power and authority to own and use its
properties and assets and to carry on its
business as currently conducted. Neither
the Company nor any Subsidiary is in
violation of any of the provisions of its
respective certificate or articles of
incorporation, bylaws or other
organizational or charter documents. Each of the
Company and the Subsidiaries is duly
qualified to conduct business and is in
good standing as a foreign corporation or
other entity in each jurisdiction in
which the nature of the business conducted
or property owned by it makes such
qualification necessary, except where the
failure to be so qualified or in good
standing, as the case may be, would not
have or result in (i) a material adverse
effect on the legality, validity or
enforceability of any Transaction Document,
(ii) a material adverse effect on the
business or financial condition of the
Company and the Subsidiaries, taken as a
whole, or (iii) a material adverse
effect on the Company's ability to perform
in any material respect on a timely
basis its obligations under any Transaction
Document (any of (i), (ii) or (iii),
a "MATERIAL ADVERSE EFFECT").
(C)
AUTHORIZATION; ENFORCEABILITY. The Company has the requisite
corporate power and authority to enter into
and to consummate the transactions
contemplated by each of the Transaction
Documents and otherwise to carry out its
obligations thereunder. The execution and
delivery of each of the Transaction
Documents by the Company and the
consummation by it of the transactions
contemplated thereby have been duly
authorized by all necessary action on the
part of the Company and no further action
is required by the Company in
connection therewith. Each Transaction
Document has been (or upon delivery will
have been) duly executed by the Company
and, when delivered in accordance with
the terms hereof, will constitute the valid
and binding obligation of the
Company enforceable against the Company in
accordance with its terms, subject to
laws of general application relating to
bankruptcy, insolvency, reorganization,
moratorium or other similar laws affecting
creditors' rights generally and rules
of law governing specific performance,
injunctive relief, or other equitable
remedies.
7
<PAGE>
(D)
NO CONFLICTS. The execution, delivery and performance of the
Transaction Documents by the Company and
the consummation by the Company of the
transactions contemplated thereby do not
and will not (i) conflict with or
violate any provision of the Company's or
any Subsidiary's certificate or
articles of incorporation, bylaws or other
organizational or charter documents,
or (ii) conflict with, or constitute a
default (or an event that with notice or
lapse of time or both would become a
default) under, or give to others any
rights of termination, amendment,
acceleration or cancellation (with or without
notice, lapse of time or both) of, any
agreement, credit facility, debt or other
instrument (evidencing a Company or
Subsidiary debt or otherwise) or other
understanding to which the Company or any
Subsidiary is a party or by which any
property or asset of the Company or any
Subsidiary is bound or affected, or
(iii) result in a violation of any law,
rule, regulation, order, judgment,
injunction, decree or other restriction of
any court or governmental authority
to which the Company or a Subsidiary is
subject (including federal and state
securities laws and regulations), or by
which any property or asset of the
Company or a Subsidiary is bound or
affected, except, in the cases of clause
(ii), where such conflict, default or
violation would not have or result in a
Material Adverse Effect.
(E)
FILINGS, CONSENTS AND APPROVALS. The Company is not required to
obtain any consent, waiver, authorization
or order of, give any notice to, or
make any filing or registration with, any
court or other federal, state, local
or other governmental authority or other
Person in connection with the
execution, delivery and performance by the
Company of the Transaction Documents,
other than (a) the filing with the
Commission of the Registration Statement, the
application(s) to each Trading Market for
the listing of the Warrant Shares for
trading thereon in the time and manner
required thereby, Form D and applicable
Blue Sky filings and (b) such as have
already been obtained or such exemptive
filings as are required to be made under
applicable securities laws.
(F)
ISSUANCE OF THE SECURITIES. The Securities are duly authorized
and, when issued and paid for in accordance
with the Transaction Documents, will
be duly and validly issued, fully paid and
nonassessable, free and clear of all
Liens, other than any Liens created by or
imposed on the holders thereof through
no action of the Company. The Company has
reserved from its duly authorized
capital stock the maximum number of shares
of Common Stock issuable pursuant to
the Warrants, including, without
limitation, such number of shares as would be
issuable pursuant to the Warrants upon the
occurrence of the contingencies
described in Section 15 of the
Warrants.
(G)
CAPITALIZATION.
(i)
The authorized and outstanding capitalization of the
Company is as described in the Company's
most recent periodic report filed with
the Commission. The Company has not issued
any capital stock since such filing,
other than pursuant to the exercise of
employee stock options under the
Company's stock option plans and pursuant
to the conversion or exercise of
Common Stock Equivalents outstanding on the
date thereof. All shares of the
Company's issued and outstanding capital
stock have been duly authorized, are
validly issued and outstanding, and are
fully paid and nonassessable. No
securities issued by the Company from May
7, 2004 to the date hereof were issued
in violation of any statutory or common law
preemptive rights. There are no
dividends which have accrued or been
declared but are unpaid on the capital
stock of the Company. All taxes required to
be paid by the Company in connection
with the issuance and any transfers of the
Company's capital stock have been
paid. Since May 7, 2004 all securities
of
8
<PAGE>
the Company have been issued in all
material respects in accordance with the
provisions of all applicable securities and
other laws.
(ii)
Except as described on Schedule 3(g)(ii), no Person has
any right of first refusal, preemptive
right, right of participation, or any
similar right to participate in the
transactions contemplated by the Transaction
Documents. Except as disclosed on Schedule
3(g)(ii) and as a result of the
purchase and sale of the Securities, there
are no outstanding options, warrants,
rights to subscribe to, calls or
commitments of any character whatsoever
relating to, or securities, rights or
obligations convertible into or
exchangeable for, or giving any Person any
right to subscribe for or acquire,
any shares of Common Stock, or contracts,
commitments, understandings or
arrangements by which the Company or any
Subsidiary is or may become bound to
issue additional shares of Common Stock, or
securities or rights convertible or
exchangeable into shares of Common Stock.
The issue and sale of the Securities
will not obligate the Company to issue
shares of Common Stock or other
securities to any Person (other than the
Purchasers) and will not result in a
right of any holder of Company securities
to adjust the exercise, conversion,
exchange or reset price under such
securities.
(H)
SEC REPORTS; FINANCIAL STATEMENTS; LIABILITIES.
(i)
The Company has filed all reports required to be filed
by it under the Securities Act and the
Exchange Act, including pursuant to
Section 13(a) or 15(d) of the Exchange Act,
for the 12 months preceding the date
hereof (or such shorter period as the
Company was required by law to file such
material) (the foregoing materials,
including the exhibits thereto, being
collectively referred to herein as the "SEC
REPORTS"). As of their respective
filing dates, the SEC Reports complied in
all material respects with the
requirements of the Securities Act and the
Exchange Act, as the case may be, and
the rules and regulations of the Commission
promulgated thereunder, as
applicable, and none of the SEC Reports, as
of their respective filing dates,
contained any untrue statement of a
material fact or omitted to state a material
fact required to be stated therein or
necessary in order to make the statements
therein, in light of the circumstances
under which they were made, not
misleading.
(ii) The
financial statements of the Company included in the
SEC Reports comply with applicable
accounting requirements and the rules and
regulations of the Commission with respect
thereto as in effect at the time of
filing. Such financial statements have been
prepared in accordance with
generally accepted accounting principles in
the United States, applied on a
consistent basis during the periods
involved ("GAAP"), except as may be
otherwise specified in such financial
statements or the notes thereto and except
that unaudited financial statements may not
contain all footnotes required by
GAAP, subject to normal year-end audit
adjustments. Such financial statements
fairly present in all material respects the
financial position of the Company
and its consolidated subsidiaries, if any,
as of and for the dates thereof and
the results of operations and cash flows
for the periods then ended, subject, in
the case of unaudited statements, to normal
year-end audit adjustments.
(iii) Except as
set forth in the SEC Reports, and except for
liabilities and obligations incurred since
June 30, 2004 in the ordinary course
of business, consistent with past practice,
as of the date hereof: (i) the
Company and its Subsidiaries do not have
any material liabilities or obligations
(absolute, accrued, contingent or
otherwise) and (ii) there has not been any
aspect of the prior or current conduct of
the business of the Company or its
Subsidiaries
9
<PAGE>
which may form the basis for any material
claim by any third party which if
asserted could result in a Material Adverse
Effect.
(I)
MATERIAL CHANGES. Since June 30, 2004, the Company has
conducted
its business only in the ordinary course,
consistent with past practice, and
there has not occurred:
(i)
any event that would have a Material Adverse Effect on
the Company or any of its Subsidiaries;
(ii) any
amendments or changes in the charter documents of
the Company and its Subsidiaries;
(iii) any
damage, destruction or loss, whether or not covered
by insurance, that would, individually or
in the aggregate, have or would be
reasonably likely to have, a Material
Adverse Effect on the Company and its
Subsidiaries;
(iv)
any:
(A)
incurrence, assumption or guarantee by the
Company or its Subsidiaries of any debt for
borrowed money other than (i)
equipment leases made in the ordinary
course of business, consistent with past
practice and (ii) any such incurrence,
assumption or guarantee with respect to
an amount of $25,000 or less that has been
disclosed in the SEC Reports;
(B)
issuance or sale of any securities convertible
into or exchangeable for securities of the
Company other than to directors,
employees and consultants pursuant to
existing equity compensation or stock
purchase plans of the Company;
(C)
issuance or sale of options or other rights to
acquire from the Company or its
Subsidiaries, directly or indirectly, securities
of the Company or any securities
convertible into or exchangeable for any such
securities, other than options issued to
directors, employees and consultants in
the ordinary course of business, consistent
with past practice;
(D)
issuance or sale of any stock, bond or other
corporate security other than to directors,
employees and consultants pursuant
to existing equity compensation or stock
purchase plans of the Company;
(E) discharge or satisfaction of
any material Lien;
(F)
declaration or making any payment or
distribution to stockholders or purchase or
redemption of any share of its
capital stock or other security other than
to directors, officers and employees
of the Company or its Subsidiaries as
compensation for services rendered to the
Company or its Subsidiary (as applicable)
or for reimbursement of expenses
incurred on behalf of the Company or its
Subsidiary (as applicable);
(G)
sale, assignment or transfer of any of its
intangible assets except in the ordinary
course of business, consistent with
past practice, or cancellation of any debt
or claim except in the ordinary
course of business, consistent with past
practice;
10
<PAGE>
(H)
waiver of any right of substantial value whether
or not in the ordinary course of
business;
(I)
material change in officer compensation, except
in the ordinary course of business and
consistent with past practice; or
(J)
other commitment (contingent or otherwise) to do
any of the foregoing.
(v)
any creation, sufferance or assumption by the Company or
any of its Subsidiaries of any Lien on any
asset or any making of any loan,
advance or capital contribution to or
investment in any Person, in an aggregate
amount which exceeds $25,000 outstanding at
any time;
(vi) any
entry into, amendment of, relinquishment,
termination or non-renewal by the Company
or its Subsidiaries of any material
contract, license, lease, transaction,
commitment or other right or obligation,
other than in the ordinary course of
business, consistent with past practice; or
(vii) any
transfer or grant of a right with respect to the
patents, trademarks, trade names, service
marks, trade secrets, copyrights or
other intellectual property rights owned or
licensed by the Company or its
Subsidiaries, except as among the Company
and its Subsidiaries.
(J)
LITIGATION. There is no action, suit, inquiry, notice of
violation, proceeding or investigation
pending or, to the knowledge of the
Company, threatened against the Company,
any Subsidiary or any of their
respective properties before or by any
court, arbitrator, governmental or
administrative agency or regulatory
authority (federal, state, county, local or
foreign) (collectively, an "ACTION") which
(i) adversely affects or challenges
the legality, validity or enforceability of
any of the Transaction Documents or
the Securities or (ii) would, if there were
an unfavorable decision, have or
result in a Material Adverse Effect.
Neither the Company nor any Subsidiary,
nor, to the knowledge of the Company, any
director or officer thereof, is or has
been the subject of any Action involving a
claim of violation of or liability
under federal or state securities laws or a
claim of breach of fiduciary duty.
To the knowledge of the Company, there has
not been and there is not pending or
contemplated, any investigation by the
Commission involving the Company or any
current or former director or officer of
the Company. The Commission has not
issued any stop order or other order
suspending the effectiveness of any
registration statement filed by the Company
or any Subsidiary under the Exchange
Act or the Securities Act.
(K)
LABOR RELATIONS. No material labor dispute exists or, to the
knowledge of the Company, is imminent with
respect to any of the employees of
the Company which would have or result in a
Material Adverse Effect.
(L)
COMPLIANCE. Neither the Company nor any Subsidiary (i) is in
default under or in violation of (and no
event has occurred that has not been
waived that, with notice or lapse of time
or both, would result in a default by
the Company or any Subsidiary under), nor
has the Company or any Subsidiary
received notice of a claim that it is in
default under or that it is in
violation of, any indenture, loan or credit
agreement or any other agreement or
instrument to which it is a party or by
which it or any of its properties is
bound (whether or not such default or
11
<PAGE>
violation has been waived), (ii) is in
violation of any order of any court,
arbitrator or governmental body, or (iii)
is or has been in violation of any
statute, rule or regulation of any
governmental authority, including without
limitation all foreign, federal, state and
local laws applicable to its
business, except in the case of clauses (i)
and (iii) as would not have or
reasonably be expected to result in a
Material Adverse Effect.
(M)
LICENSES; COMPLIANCE WITH REGULATORY REQUIREMENTS. The Company
holds all material authorizations,
consents, approvals, franchises, licenses and
permits required under applicable law or
regulation for the operation of the
business of the Company and its
Subsidiaries as presently operated (the
"GOVERNMENTAL AUTHORIZATIONS"). All the
Governmental Authorizations have been
duly issued or obtained and are in full
force and effect, and the Company and
its Subsidiaries are in material compliance
with the terms of all the
Governmental Authorizations. The Company
and its Subsidiaries have not engaged
in any activity that, to the Company's
knowledge, would cause revocation or
suspension of any such Governmental
Authorizations. The Company has no knowledge
of any facts which would reasonably be
expected to cause the Company to believe
that the Governmental Authorizations will
not be renewed by the appropriate
governmental authorities in the ordinary
course. Neither the execution, delivery
nor performance of this Agreement shall
adversely affect the status of any of
the Governmental Authorizations.
(N)
TITLE TO ASSETS. The Company and the Subsidiaries do not own
any
real property, and have good and marketable
title to all personal property owned
by them that is material to the business of
the Company and the Subsidiaries,
taken as a whole, in each case free and
clear of all Liens, except those, if
any, reflected in the Company's financial
statements or disclosed on Schedule
3.1(n). Any real property and facilities
held under lease by the Company and the
Subsidiaries are held by them under valid,
subsisting and enforceable leases
(subject to laws of general application
relating to bankruptcy, insolvency,
reorganization, moratorium or other similar
laws affecting creditors' rights
generally and rules of law governing
specific performance, injunctive relief, or
other equitable remedies) with which the
Company and the Subsidiaries are in
material compliance.
(O)
INTELLECTUAL PROPERTY.
(i)
The Company or a Subsidiary thereof has the right to use
or is the sole and exclusive owner of all
right, title and interest in and to
all foreign and domestic patents, patent
rights, trademarks, service marks,
trade names, brands and copyrights (whether
or not registered and, if
applicable, including pending applications
for registration) owned, used or
controlled by the Company and its
Subsidiaries (collectively, the "RIGHTS") and
in and to each material invention,
software, trade secret, technology, product,
composition, formula and method of process
used by the Company or its
Subsidiaries (the Rights and such other
items, the "INTELLECTUAL PROPERTY"),
and, to the Company's knowledge, has the
right to use the same, free and clear
of any claim or conflict with the rights of
others;
(ii) other
than as set forth in the SEC Reports, no royalties
or fees (license or otherwise) are payable
by the Company or its Subsidiaries to
any Person by reason of the ownership or
use of any of the Intellectual
Property;
12
<PAGE>
(iii) there have
been no claims made against the Company or
its Subsidiaries asserting the invalidity,
abuse, misuse, or unenforceability of
any of the Intellectual Property, and, to
the best of the Company's knowledge,
there are no reasonable grounds for any
such claims;
(iv)
neither the Company nor its Subsidiaries have made any
claim of any violation or infringement by
others of its rights in the
Intellectual Property, and to the best of
the Company's knowledge, no reasonable
grounds for such claims exist; and
(v)
neither the Company nor its Subsidiaries have received
notice that it is in conflict with or
infringing upon the asserted rights of
others in connection with the Intellectual
Property.
(P)
INSURANCE. The Company and the Subsidiaries are insured by
insurers of recognized financial
responsibility against such losses and risks
and in such amounts as are prudent and
customary in the businesses in which the
Company and the Subsidiaries are engaged.
All of the insurance policies of the
Company and its Subsidiaries are in full
force and effect and are valid and
enforceable in accordance with their terms,
and the Company and its Subsidiaries
have complied with all material terms and
conditions thereof. Neither the
Company nor any Subsidiary has any reason
to believe that it will not be able to
renew its existing insurance coverage as
and when such coverage expires or to
obtain similar coverage from similar
insurers as may be necessary to continue
its business without a significant increase
in cost.
(Q)
TRANSACTIONS WITH AFFILIATES AND EMPLOYEES. None of the
officers
or directors of the Company and, to the
knowledge of the Company, none of the
employees of the Company is presently a
party to any transaction with the
Company or any Subsidiary (other than for
services as employees, officers and
directors), including any contract,
agreement or other arrangement providing for
the furnishing of services to or by,
providing for rental of real or personal
property to or from, or otherwise requiring
payments to or from any officer,
director or such employee or, to the
knowledge of the Company, any entity in
which any officer, director, or any such
employee has a substantial interest or
is an officer, director, trustee or
partner, other than (a) for payment of
salary or consulting fees for services
rendered, (b) reimbursement for expenses
incurred on behalf of the Company and (c)
for other employee benefits, including
stock option agreements and other stock
awards under any equity compensation
plan of the Company.
(R)
INTERNAL ACCOUNTING CONTROLS. The Company and each of the
Subsidiaries maintains a system of internal
accounting controls sufficient in
the judgment of the Company's